Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F Graziano
Reply: KRAS Status Analysis and Anti-Egfr Therapies: Is Comprehensiveness a Biologist's Fancy or a Clinical Necessity?
British Journal of Cancer
Cancer Research
Oncology
Related publications
EGFR Status in Mesothelioma: Possible Implications for the Efficacy of Anti-Egfr and Anti-Met Therapies
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Reply: EGFR Alterations and Response to Anti-Egfr Therapy: Is It a Matter of Gene Amplification or Gene Copy Number Gain?
British Journal of Cancer
Cancer Research
Oncology
EGFR Alterations and Response to Anti-Egfr Therapy: Is It a Matter of Gene Amplification or Gene Copy Number Gain?
British Journal of Cancer
Cancer Research
Oncology
Emergence of KRAS Mutations and Acquired Resistance to Anti-Egfr Therapy in Colorectal Cancer
Nature
Multidisciplinary
Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to EGFR and KRAS Mutation Status
PLoS ONE
Multidisciplinary
The 26S Proteasome Is a Multifaceted Target for Anti-Cancer Therapies
Oncotarget
Oncology
Common and Rare EGFR and KRAS Mutations in a Dutch Non-Small-Cell Lung Cancer Population and Their Clinical Outcome
PLoS ONE
Multidisciplinary
Dance Notation : A Historical Fact or a Necessity
SOCIETY, INTEGRATION, EDUCATION. Proceedings of the International Scientific Conference
GC1118, a Novel Anti-Egfr Antibody, Has Potent KRAS Mutation-Independent Antitumor Activity Compared With Cetuximab in Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology